As the world responds to the COVID-19 pandemic, we are seeing both the value and the need for public-private partnerships to quickly get much-needed medical innovations and technologies to combat infection in the hands of healthcare workers, patients and the general public. In collaboration with government authorities, private companies have stepped up to the plate to manufacture, with urgency, the diagnostic test kits required to identify those with infection. And others, like Johnson & Johnson, are working tirelessly with the aim to identify a vaccine to prevent future outbreaks.